M Katerji
Neurology with Special Qualifications in Child Neurology · Naperville, ILNPI 1295736726
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,087 of the $52,362 with a category attached, or 70.8%. Supernus Pharmaceuticals, Inc. accounts for 83.2% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2023 at $20,294 and has fallen 94.4% since, to $1,137 in 2025.
Across 584 payments — averaging $89.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$44K
- Corium, LLC$799
- UCB, Inc.$778
- Catalyst Pharmaceuticals, Inc.$770
- Livanova USA, Inc.$744
- AbbVie$601
- plus $5K from 26 others
What the payments were for
- Speaking & faculty fees$37,08771%
- Travel & lodging$3,6947%
- Food & beverage$11,52822%
- Education$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 177 | $43,586 |
| Corium, LLC | 41 | $799 |
| UCB, Inc. | 45 | $778 |
| Catalyst Pharmaceuticals, Inc. | 25 | $770 |
| Livanova USA, Inc. | 17 | $744 |
| AbbVie(2 entities) | 33 | $601 |
| Tris Pharma Inc | 35 | $575 |
| Greenwich Biosciences, Inc. | 14 | $556 |
| SK Life Science, Inc. | 19 | $453 |
| Ironshore Pharmaceuticals Inc. | 20 | $441 |
| Sunovion Pharmaceuticals Inc. | 20 | $374 |
| Neurelis, Inc. | 11 | $341 |
| Eisai Inc. | 21 | $341 |
| Upsher-smith Laboratories LLC | 16 | $266 |
| Neos Therapeutics, LP | 14 | $233 |
| Jazz Pharmaceuticals Inc. | 9 | $226 |
| Teva Pharmaceuticals USA, Inc. | 5 | $187 |
| Sumitomo Pharma America, Inc. | 10 | $171 |
| Mallinckrodt Enterprises LLC | 3 | $169 |
| Currax Pharmaceuticals LLC | 12 | $161 |
| Shire North American Group Inc | 12 | $129 |
| Adlon Therapeutics L.p. | 5 | $88 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Noven Therapeutics, LLC | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| Amgen | 2 | $36 |
| Assertio Therapeutics, Inc. | 2 | $31 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Novartis | 1 | $22 |
| Aprecia Pharmaceuticals, LLC | 1 | $20 |
| Zogenix Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$35,236
- TROKENDI XR$1,500
- OXTELLAR XR$623
- Fycompa$379
- Epidiolex$357
- Jornay PM 20mg capsules (Bottle of 100)$125
- AJOVY$125
- VNS Therapy$125
- VALTOCO$124
- ACTHAR$121
How this compares
$52,363 in reported general payments places this provider in the 85th percentile of 57 neurology with special qualifications in child neurology providers in Illinois.
See all neurology with special qualifications in child neurology providers in Illinois →
Other neurology with special qualifications in child neurology in Naperville
- Douglas NordliChicago$621K
- Nancy KuntzChicago$503K
- Ryan CoatesOak Lawn$163K
- Vamshi RaoChicago$124K
- Takijah HeardEvanston$94K
- John MillichapChicago$84K
- Sookyong KohChicago$60K
- Charles MarcuccilliBurr Ridge$42K
- Elizabeth Berry-KravisChicago$38K
- Colleen BuhrfiendChicago$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.